ExoRNA Bio announced that it has received tens of millions in angel + rounds of financing led by new investor Guangzhou Yuexiu Industrial Investment Fund Management Co., Ltd. on May 15, 2023. The transaction included participation from new investors Zhejiang Jingxin Pharmaceutical Co., Ltd., Dingxin Capital Co., Ltd. and Nanjing University Biomedical Industry Alumni Association, returning investor CDH Investment Management Company Limited. The company issued common shares in the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.07 CNY | -0.82% | +1.77% | -5.11% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.11% | 1.44B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 002020 Stock
- News Zhejiang Jingxin Pharmaceutical Co., Ltd.
- ExoRNA Bio announced that it has received funding from Guangzhou Yuexiu Industrial Investment Fund Management Co., Ltd., Zhejiang Jingxin Pharmaceutical Co., Ltd., Dingxin Capital Co., Ltd., CDH Investment Management Company Limited and other investors